## Table of Contents

---

## Gross profit/(loss) and gross margin

### Three months ended September 30,
| Description | 2024 | 2023 | Change |
|-------------|------|------|--------|
| **Gross profit/(loss)** | | | |
| Premium | 1,178 | 848 | 330 (39%) |
| Ad-Supported | 62 | 37 | 25 (N/M*) |
| **Consolidated** | 1,240 | 885 | 355 (40%) |
| **Gross margin** | | | |
| Premium | 34% | 29% | 5% |
| Ad-Supported | 13% | 8% | 5% |
| **Consolidated** | 31% | 26% | 5% |

### Nine months ended September 30,
| Description | 2024 | 2023 | Change |
|-------------|------|------|--------|
| **Gross profit/(loss)** | | | |
| Premium | 3,208 | 2,413 | 795 (33%) |
| Ad-Supported | 148 | 4 | 144 (N/M*) |
| **Consolidated** | 3,356 | 2,417 | 939 (39%) |
| **Gross margin** | | | |
| Premium | 32% | 29% | 3% |
| Ad-Supported | 11% | - | - |
| **Consolidated** | 29% | 25% | 4% |

*N/M = Not Meaningful

## Premium gross profit and gross margin

### Three months ended September 30, 2024
Premium gross profit increased by €330 million, and Premium gross margin increased from 29% to 34%. Benefits are primarily due to revenue growth outpacing music royalty costs and a reduction in streaming delivery costs during the three months ended September 30, 2024.

### Nine months ended September 30, 2024
Premium gross profit increased by €795 million, and Premium gross margin rose from 29% to 32%. This increase was largely due to benefits from certain marketplace programs and additional revenue outpacing licensing costs.

## Ad-Supported gross profit/(loss) and gross margin

### Three months ended September 30, 2024
Ad-Supported gross profit increased by €25 million, and gross margin increased from 8% to 13%. The increase was supported by a reduction in costs related to podcast production and streaming services.

### Nine months ended September 30, 2024
Ad-Supported gross profit increased by €144 million, and the gross margin rose from 11%. The significant margin improvement was primarily due to a strategic realignment and cost reductions in content rights and personnel.

## Consolidated Operating Expenses

### Research and development costs

| | Three months ended September 30, 2024 | Nine months ended September 30, 2024 |
|-------|-------------------------------------|-------------------------------------|
| R&D | 342 (9% of revenue) | 1,110 (10% of revenue) |
| Change | 369 (11% of revenue) to 342 (9% of revenue) (-27, -7%) | 1,257 (13% of revenue) to 1,110 (10% of revenue) (-147, -12%) |